Ambiopharm's Series A Round

Ambiopharm raised a round of funding on November 20, 2014. Investors include MVM Life Science Partners.

AmbioPharm (APi) has developed a new business model responsive to an accelerating trend to drive down costs of manufacturing peptides. The company has established a new custom peptide supply service d…

Articles about Ambiopharm's Series A Round: